Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Switch therapy studies

P W Mallon1

  • 1University of New South Wales, HIV, Immunology and Infectious Diseases Clinical Services Unit, St Vincent's Hospital Medical Centre, 376 Victoria Street, Sydney, NSW 2010, Australia. pmallon@nchecr.unsw.edu.au

Journal of HIV Therapy
|August 17, 2001
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antiretroviral treatment outcomes among late HIV presenters initiating treatment with integrase inhibitors or protease inhibitors.

HIV medicine·2020
Same author

Estimated glomerular filtration rate slopes on tenofovir alafenamide.

HIV medicine·2020
Same author

Level of agreement between frequently used cardiovascular risk calculators in people living with HIV.

HIV medicine·2019
Same author

Two-drug vs. three-drug combinations for HIV-1: Do we have enough data to make the switch?

HIV medicine·2019
Same author

Associations between cognitive impairment and patient-reported measures of physical/mental functioning in older people living with HIV.

HIV medicine·2016
Same author

Effect of nucleoside reverse transcriptase inhibitors on CD4 T-cell recovery in HIV-1-infected individuals receiving long-term fully suppressive combination antiretroviral therapy.

HIV medicine·2009
Same journal

Implications of the SILCAAT and ESPRIT trials and the future for HIV immunotherapy.

Journal of HIV therapy·2010
Same journal

A review of the use of activation markers in Africa.

Journal of HIV therapy·2010
Same journal

Lymphocyte activation in HIV-1 infection: time for quality control.

Journal of HIV therapy·2010
Same journal

HIV immunology: what lessons can we learn from recent vaccine trials?

Journal of HIV therapy·2010
Same journal

SILCAAT and ESPRIT: taking stock.

Journal of HIV therapy·2010
Same journal

HIV, atherosclerosis and inflammation: implications for treatment.

Journal of HIV therapy·2010
See all related articles